Home » Topics » Regulatory » Health Canada

Health Canada
RSS

Graceway receives Canadian approval for topical genital warts treatment Vyloma 3.75%

March 24, 2011

Astellas' Protopic approved in Canada for prevention of eczema flares

Feb. 18, 2011

AMAG receives NON from Health Canada regarding Feraheme submission

Feb. 9, 2011

Health Canada approves Vyvanse for ADHD in adolescents and adults

Feb. 4, 2011

Prolia available in Quebec for postmenopausal osteoporosis

Feb. 3, 2011

DigiFab approved in Canada to treat digoxin toxicity/overdose

Feb. 1, 2011

Health Canada approves once-daily antidepressant Oleptro

Jan. 21, 2011

FDA and Health Canada grant telaprevir priority review for HCV infection

Jan. 21, 2011

Eli Lilly's Byetta is approved in Canada for type 2 diabetes

Jan. 19, 2011

Health Canada requests more information from Osiris regarding Prochymal approval

Jan. 18, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...